scispace - formally typeset
A

Alan R. Zinsmeister

Researcher at Mayo Clinic

Publications -  542
Citations -  56210

Alan R. Zinsmeister is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Population & Gastric emptying. The author has an hindex of 118, co-authored 542 publications receiving 52909 citations. Previous affiliations of Alan R. Zinsmeister include University of Rochester & University of Southern California.

Papers
More filters
Journal ArticleDOI

Early measles virus infection is associated with the development of inflammatory bowel disease.

TL;DR: Early measles infection is associated with an increased risk of developing Crohn's disease and ulcerative colitis, and the risk may be higher with earlier infection.
Journal ArticleDOI

1α,25-Dihydroxyvitamin D3Increases Transforming Growth Factor and Transforming Growth Factor Receptor Type I and II Synthesis in Human Bone Cells

TL;DR: Examination of the effects of 1 alpha,25(OH)2D3 on the synthesis of TGF beta and TGF-beta receptors in osteoblasts found it possible to account for the inhibition of human osteoblast growth seen following 1alpha,25-dihydroxyvitamin D3 treatment.
Journal ArticleDOI

The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community

TL;DR: The objectives were to estimate the incidence rate and clinical features of DD in the community and to describe the clinical and objective features of impaired rectal evacuation.
Journal ArticleDOI

Perianal Crohn's disease findings other than fistulas in a population-based cohort.

TL;DR: Female gender and extraintestinal manifestations were associated with increased risks for perianal lesions other than fistulas, while older age at diagnosis was associated with a slightly decreased risk.
Journal ArticleDOI

Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption

TL;DR: In the absence of overt BAM, the total, primary, and secretory BAs in stool contribute to the acceleration of colonic transit and fecal weight in the diarrhea of patients with IBS‐D.